Search research articles
Contact Us
Filters
Showing results (191-200 of 266) with videos related to
Page
of 27
Sort By:
The Journal of Urology
|
June 25, 2020
Reply by Authors
Wei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 2, 2017
What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?
Rashid Khalid Sayyid, Dharmendra Dingar, Katherine Fleshner, et al.
Urologic Oncology
|
January 26, 2021
Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
Jaime O Herrera-Caceres, Alexandra Gleave, Katherine Lajkosz, et al.
Sexual Medicine
|
November 11, 2025
Virtual versus in-person sexual rehabilitation for prostate cancer survivors: a retrospective cohort study comparing the Prostate Cancer Rehabilitation Clinic (PCRC) and the True North Sexual Health and Rehabilitation eClinic (SHAReClinic)
Andrew G Matthew, Steven Guirguis, Taylor Incze, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2013
Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients
Dennis Wagner, Dominique Trudel, Theodorus Van der Kwast, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 19, 2012
Canadian Consensus Conference: The FDA decision on the use of 5ARIs
Laurence Klotz, Michael Chetner, Joseph Chin, et al.
Oncotarget
|
October 4, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer
Nicole M A White-Al Habeeb, Linh T Ho, Ekaterina Olkhov-Mitsel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 23, 2021
The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy
Hanan Goldberg, Faizan K Mohsin, Thenappan Chandrasekar, et al.
Prostate Cancer and Prostatic Diseases
|
July 10, 2020
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study
Hanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology
|
September 24, 2020
Reply by Authors
Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 266) with videos related to
Sort By:
Page
of 27
The Journal of Urology
|
June 25, 2020
Reply by Authors
Wei-Lin Winnie Wang, Igor Sorokin, Ilija Aleksic, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
May 2, 2017
What false-negative rates of non-invasive testing are active surveillance patients and uro-oncologists willing to accept in order to avoid prostate biopsy?
Rashid Khalid Sayyid, Dharmendra Dingar, Katherine Fleshner, et al.
Urologic Oncology
|
January 26, 2021
Defining oligometastatic hormone sensitive prostate cancer and clinically significant outcomes: Implications on clinical trials?
Jaime O Herrera-Caceres, Alexandra Gleave, Katherine Lajkosz, et al.
Sexual Medicine
|
November 11, 2025
Virtual versus in-person sexual rehabilitation for prostate cancer survivors: a retrospective cohort study comparing the Prostate Cancer Rehabilitation Clinic (PCRC) and the True North Sexual Health and Rehabilitation eClinic (SHAReClinic)
Andrew G Matthew, Steven Guirguis, Taylor Incze, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2013
Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients
Dennis Wagner, Dominique Trudel, Theodorus Van der Kwast, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
April 19, 2012
Canadian Consensus Conference: The FDA decision on the use of 5ARIs
Laurence Klotz, Michael Chetner, Joseph Chin, et al.
Oncotarget
|
October 4, 2014
Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer
Nicole M A White-Al Habeeb, Linh T Ho, Ekaterina Olkhov-Mitsel, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 23, 2021
The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy
Hanan Goldberg, Faizan K Mohsin, Thenappan Chandrasekar, et al.
Prostate Cancer and Prostatic Diseases
|
July 10, 2020
The deleterious association between proton pump inhibitors and prostate cancer-specific mortality - a population-based cohort study
Hanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
The Journal of Urology
|
September 24, 2020
Reply by Authors
Dominik Deniffel, Emmanuel Salinas, Marc Ientilucci, et al.
Page
of 27